Huiyi Feng

A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?

Meijun Long, Weijuan Jia, Shunrong Li et al. · Breast Cancer Research and Treatment · 2011 · 52 citations

Medicine, Oncology, Pharmacology +11

LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma

Yinxin Zhu, Chi Han Li, Guolin Li et al. · Cellular and Molecular Gastroenterology and Hepatology · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17

HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy

Haixia Jia, Weijuan Jia, Yaping Yang et al. · World Journal of Surgical Oncology · 2014 · 25 citations · Full text

Medicine, Oncology, Surgery +17

ACAA1 Is a Predictive Factor of Survival and Is Correlated With T Cell Infiltration in Non-Small Cell Lung Cancer

Huiyi Feng, Weixi Shen · Frontiers in Oncology · 2020 · 19 citations · Full text

Medicine, Molecular Biology, Oncology +17

HER2-enriched Tumors Have the Highest Risk of Local Recurrence in Chinese Patients Treated with Breast Conservation Therapy

Weijuan Jia, Haixia Jia, Huiyi Feng et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 17 citations · Full text

Medicine, Oncology, Breast Oncology +16